Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLANETRA: CT-P13 vs Remicade in Rheumatoid Arthritis
NCT01217086Phase 3Completed
- Sponsor
- Celltrion
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab-dyyb in rheumatoid arthritis (RA), sponsored by Celltrion. Started Oct 2010; status: completed.
02
Drugs
infliximab-dyyb
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01217086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217086.